Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Lymphoma 31Lymphoma, Large B-Cell, Diffuse 28Burkitt Lymphoma 18Prostatic Neoplasms 16Lymphoma, Non-Hodgkin 14Precursor Cell Lymphoblastic Leukemia-Lymphoma 13Multiple Myeloma 12Lymphoma, Follicular 11Leukemia 11Hodgkin Disease 8Lymphoma, Mantle-Cell 7Neoplasms, Plasma Cell 6Lymphoma, Large-Cell, Immunoblastic 6Lymphoma, B-Cell, Marginal Zone 6Lymphoma, B-Cell 6Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 5Neoplasms 4Myelodysplastic Syndromes 4Lymphoma, Large-Cell, Anaplastic 4Leukemia, Lymphocytic, Chronic, B-Cell 4Plasmablastic Lymphoma 3Lymphoproliferative Disorders 3Lymphoma, T-Cell 3Lymphoma, Primary Effusion 3Lymphoma, AIDS-Related 3Hematologic Neoplasms 3HIV Infections 3Thrombocythemia, Essential 2Primary Myelofibrosis 2Polycythemia Vera 2

Interventions

fludarabine 2Sirolimus 2Mycophenolic Acid 2Filgrastim 2Cyclophosphamide 2posaconazole 1pegfilgrastim 1obinutuzumab 1montelukast 1ibrutinib 1Whole-Body Irradiation 1Voriconazole 1Tomography, X-Ray Computed 1Respiratory Function Tests 1Prednisone 1Mesna 1Interleukin-15 1Erythropoietin 1Electrocardiography 1Busulfan 1Budesonide 1Blood Transfusion 1Beclomethasone 1B3(Fv)-PE38KDEL recombinant immunotoxin 1Azithromycin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Bronchiolitis Obliterans Syndrome × Prednisone × Clear all
NCT04294641 2026-01-23

Front Line Ibrutinib Without Corticosteroids for Newly Diagnosed Chronic Graft-versus-Host Disease

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
10 enrolled 15 charts
Other hematologic neoplasm

Bronchiolitis Obliterans Syndrome, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡